loadpatents
Patent applications and USPTO patent grants for Good; Andrew Charles.The latest application filed is for "cereblon binders for the degradation of ikaros".
Patent | Date |
---|---|
Tricyclic degraders of Ikaros and Aiolos Grant 11,407,732 - Henderson , et al. August 9, 2 | 2022-08-09 |
Cereblon Binders For The Degradation Of Ikaros App 20210009559 - Henderson; James A. ;   et al. | 2021-01-14 |
Therapeutic compounds and uses thereof Grant 10,358,437 - Albrecht , et al. | 2019-07-23 |
Therapeutic compounds and uses thereof Grant 10316023 - | 2019-06-11 |
Therapeutic compounds and uses thereof Grant 10,308,614 - Albrecht , et al. | 2019-06-04 |
Therapeutic compounds and uses thereof Grant 10,301,253 - Albrecht , et al. | 2019-05-28 |
Therapeutic compounds and uses thereof Grant 10,155,764 - Albrecht , et al. Dec | 2018-12-18 |
Therapeutic Compounds And Uses Thereof App 20180086720 - Albrecht; Brian K. ;   et al. | 2018-03-29 |
Therapeutic Compounds And Uses Thereof App 20180009735 - Albrecht; Brian K. ;   et al. | 2018-01-11 |
Therapeutic Compounds And Uses Thereof App 20170334883 - Albrecht; Brian K. ;   et al. | 2017-11-23 |
Therapeutic Compounds And Uses Thereof App 20170275289 - Albrecht; Brian K. ;   et al. | 2017-09-28 |
Hepatitis C Virus Inhibitors App 20120330019 - Wang; Xiangdong Alan ;   et al. | 2012-12-27 |
Hepatitis C virus inhibitors Grant 7,741,281 - D'Andrea , et al. June 22, 2 | 2010-06-22 |
Hepatitis C virus inhibitors Grant 7,592,336 - Sin , et al. September 22, 2 | 2009-09-22 |
Hepatitis C virus inhibitors Grant 7,449,479 - Wang , et al. November 11, 2 | 2008-11-11 |
Hepatitis C virus inhibitors App 20080152619 - Sin; Ny ;   et al. | 2008-06-26 |
Hepatitis C virus inhibitors Grant 7,323,447 - Sin , et al. January 29, 2 | 2008-01-29 |
Hepatitis C virus inhibitors Grant 7,309,708 - Tu , et al. December 18, 2 | 2007-12-18 |
Hepatitis C virus inhibitors App 20070099825 - D'Andrea; Stanley ;   et al. | 2007-05-03 |
Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus Grant 7,173,004 - McPhee , et al. February 6, 2 | 2007-02-06 |
Hepatitis C virus inhibitors App 20060183694 - Sin; Ny ;   et al. | 2006-08-17 |
Hepatitis C virus inhibitors App 20060172950 - Wang; Xiangdong Alan ;   et al. | 2006-08-03 |
Hepatitis C virus inhibitors Grant 7,041,698 - Ripka , et al. May 9, 2 | 2006-05-09 |
Hepatitis C virus inhibitors Grant 6,995,174 - Wang , et al. February 7, 2 | 2006-02-07 |
Hepatitis C virus inhibitors App 20050143316 - Tu, Yong ;   et al. | 2005-06-30 |
Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus App 20050090432 - McPhee, Fiona ;   et al. | 2005-04-28 |
Heterocyclicsulfonamide hepatitis C virus inhibitors Grant 6,869,964 - Campbell , et al. March 22, 2 | 2005-03-22 |
Inhibitors of hepatitis C virus Grant 6,867,185 - Campbell , et al. March 15, 2 | 2005-03-15 |
Hepatitis C virus inhibitors App 20040106559 - Wang, Xiangdong Alan ;   et al. | 2004-06-03 |
Heterocyclicsulfonamide hepatitis C virus inhibitors App 20040072761 - Campbell, Jeffrey Allen ;   et al. | 2004-04-15 |
Hepatitis C virus inhibitors App 20040048802 - Ripka, Amy ;   et al. | 2004-03-11 |
Inhibitors of hepatitis C virus App 20040038872 - Campbell, Jeffrey Allen ;   et al. | 2004-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.